Dolutegravir CAS 1051375-16-6

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

1051375-16-6

Name

Dolutegravir

Synonyms

(4R,12aS)-N-(2,4-Difluorbenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-9-carboxamid [German] [ACD/IUPAC Name]
(4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [ACD/IUPAC Name]
(4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-méthyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [French] [ACD/IUPAC Name]
(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
1051375-16-6 [RN]
2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)- [ACD/Index Name]
9261
DKO1W9H7M1
Dolutegravir [INN] [USAN] [Wiki]
Dolutegravir [Spanish] [INN]
Dolutégravir [French] [INN]
Dolutegravirum [Latin] [INN]
GSK 1349572
S-349572
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0³,â¸]tetradeca-10,13-diene-13-carboxamide
(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide
(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1 ,3]oxazine-9-carboxamide
(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide
[1051375-16-6]
1051375-19-9 [RN]
DLU
Dolutegravir (GSK1349572)
Dolutegravir(S/GSK1349572)
dolutegravir/GSK1349572/S-349572
GSK 1349572|GSK-1349572|GSK1349572|S-349572|Tivicay®
GSK1349572
GSK-1349572
MFCD20488027
S/GSK 1349572
S/GSK1349572
S/GSK1349572 (GSK1349572)
S/GSK1349572;GSK1349572;S/GSK 1349572;GSK-1349572;GSK 1349572
Tivicay [Trade name]
Tivicay®
UNII:DKO1W9H7M1
UNII-DKO1W9H7M1

Molecular Structure

Structure of Dolutegravir CAS 1051375-16-6

SMILES

C[C@@H]1CCO[C@@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)O

StdInChI

InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1

StdInChIKey

RHWKPHLQXYSBKR-BMIGLBTASA-N

Molecular Formula

C20H19F2N3O5

Molecular Weight

419.3787664

Safety Data

WGK Germany

3

Specifications and Other Information of Our Dolutegravir CAS 1051375-16-6

Standard

Enterprise standard

Purity

99%min

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the new drug of Anti-AIDS.

Links

Watson International Ltd

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/dolutegravir-cas-1051375-16-6/”